TG Therapeutics Inc said on Wednesday that the U.S. health regulator had approved its monoclonal antibody for treating patients with relapsing forms of multiple sclerosis, sending its shares up. | December 28, 2022
U S FDA approves TG Therapeutics multiple sclerosis drug streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
(Reuters) - The U.S. health regulator on Wednesday approved TG Therapeutics Inc's drug for patients with relapsing forms of multiple sclerosis, pittin.
Biogen reveals new data for MS therapies Tysabri and Vumerity pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.